Brief: Cipla Says USFDA Conducts Inspection At Invagen Facility In New York
Today 04:33
BRIEF-Cipla Says USFDA Conducts Inspection At Invagen Facility In New York Oct 23 (Reuters) - Cipla Ltd CIPL.NS:
USFDA CONDUCTS INSPECTION AT INVAGEN FACILITY IN NEW YORK FROM OCT 19-22, 2026
INSPECTION CONCLUDES WITH ZERO FORM 483 OBSERVATIONS
Source text: ID:nBSE60mn4c
Further company coverage: CIPL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipla
See all newsBrief: Cipla Says USFDA Conducts Inspection At Invagen Facility In New York
Factbox: Global healthcare companies invest billions to boost US presence
Brief: Cipla, Qilu Pharmaceutical Partner For Licensing, Supply Of Biosimilar To Keytruda In US
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
Brief: Cipla Enters Exclusive Partnership With Qilu For Keytruda Biosimilar In US